A Multiple Ascending Dose Study in Healthy Volunteers and Patients With Alzheimer's Disease
Completed · Phase 1 · Has a placebo group
Conditions studied: Alzheimer's Disease
In brief
A Phase 1b Multiple Ascending Dose Study of the Safety and Tolerability of BMS-984923 in Healthy Older Adults and Patients with Alzheimer's Disease
Key facts
- Study ID
- NCT05804383
- Run by
- Allyx Therapeutics
- People needed
- 51
- Starts
- 2023-03-28
- Expected to finish
- 2025-10-15
- Last updated by the study team
- 2025-11-06
Who can join
Age: 50 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Yale University — New Haven, Connecticut, United States
- Spaulding Clinical Research — West Bend, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.